Can Endoscopic Bleeding Control Improve the Prognosis of Advanced Gastric Cancer Patients?: A Retrospective

Hyungchul Park1, Ji Yong Ahn, Hwoon-Yong Jung

  • 1Departments of *Internal Medicine †Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Insights

Gastric bleeding in cancer patients impacts survival. Successful endoscopic bleeding control is crucial for improving prognosis, though rebleeding can occur. This study highlights the importance of effective hemostasis.

Area of Science:

  • Gastroenterology
  • Oncology
  • Endoscopic Surgery

Background:

  • Gastric bleeding is a frequent complication in gastric cancer patients, posing treatment challenges.
  • The impact of gastric bleeding on survival and the efficacy of bleeding control require further investigation.

Purpose of the Study:

  • To determine if gastric bleeding affects survival in gastric cancer patients.
  • To assess if successful bleeding control improves prognosis in these patients.

Main Methods:

  • Retrospective review of 64 gastric cancer patients with bleeding undergoing endoscopic therapy (bleeding group).
  • Matched 1:2 with 128 gastric cancer patients without bleeding (control group) by age, sex, and cancer stage.
  • Analysis of survival, bleeding treatment methods, hemostasis success, and rebleeding rates.

Main Results:

  • Initial hemostasis rate was 73.4%, with coagrasper being the most common treatment.
  • Successful bleeding control was achieved in 47 patients, with a 36.2% rebleeding rate within 3 days.
  • Median survival was significantly longer in the control group (18.5 mo) versus the bleeding group (6.5 mo), and in successful (8.5 mo) versus failed bleeding control groups (1.8 mo).

Conclusions:

  • Successful bleeding control is a critical factor for improving survival in gastric cancer patients experiencing bleeding.
  • Risk factors for bleeding include specific tumor types (Borrmann II, IV) and use of antiplatelet/anticoagulant medications.
Abstract